Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$10.06
0.606.34%
At close: -
$10.06
0.000.00%
After Hours: May 16, 4:00 PM EDT
Comments
Loading...
Oruka Therapeutics (ORKA) Forecast
NewsEarningsOruka Therapeutics (ORKA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Oruka Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ORKA | Benzinga
Explore Oruka Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ORKA.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Oruka Therapeutics (ORKA) stock?
You can purchase shares of Oruka Therapeutics (NASDAQ:ORKA) through any online brokerage.
Who are Oruka Therapeutics (ORKA) competitors?
Other companies in Oruka Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Precigen (NASDAQ:PGEN), Prothena Corp (NASDAQ:PRTA), Olema Pharmaceuticals (NASDAQ:OLMA) and ORIC Pharmaceuticals (NASDAQ:ORIC).
What is the forecast, or price target, for Oruka Therapeutics (ORKA) stock?
Oruka Therapeutics has a consensus price target of $40.33.
What is the current price for Oruka Therapeutics (ORKA)?
The stock price for Oruka Therapeutics (NASDAQ: ORKA) is $10.06 last updated May 16, 2025 at 4:00 PM EDT.
Does Oruka Therapeutics (ORKA) pay a dividend?
A quarterly cash dividend of 1.61 per share of Class A Common Stock. The quarterly cash dividend was payable on August 28, 2024 to stockholders of record on August 26, 2024.
When is Oruka Therapeutics (NASDAQ:ORKA) reporting earnings?
Oruka Therapeutics’s Q2 earnings are confirmed for Friday, August 15, 2025.
Is Oruka Therapeutics (ORKA) going to split?
There is no upcoming split for Oruka Therapeutics.
What sector and industry does Oruka Therapeutics (ORKA) operate in?
Oruka Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
